EUVIMEDEUVIMED entdecken
Crossref

Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease

Bhavin Patel, Rachana Patel, Manjusha Yadav, Ashish Susvirkar, Avani Jain, Haresh Shah

Neurology and Clinical Neuroscience · 18.11.2026

DOI: 10.1002/ncn3.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Clinical Neuroscience, online erschienen am 18.11.2026. Verfasst von Bhavin Patel und 5 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti‐IgLON5 disease is a rare neurological disorder with overlapping autoimmune and neurodegenerative features, often leading to delayed diagnosis due to phenotypic heterogeneity. Early identification of immune‐dominant cases is crucial, as they may respond to immunotherapy. We report a 67‐year‐old male presenting with progressive bulbar dysfunction, sleep‐disordered breathing, and intermittent hypercapnic respiratory failure over 6 months. Structural neuroimaging and cerebrospinal fluid analysis were unremarkable. FDG‐PET brain imaging suggested a neurodegenerative pattern; however, preserved dopaminergic uptake on 18F‐DOPA PET did not support a significant presynaptic nigrostriatal dopaminergic deficit. Polysomnography confirmed severe obstructive sleep apnea with nocturnal hypoventilation. Serum anti‐IgLON5 antibodies were very strongly positive on a tissue‐based assay using indirect immunofluorescence at a 1:10 dilution and were subsequently confirmed by a cell‐based assay. CSF anti‐IgLON5 antibody testing was not performed. Serum neurofilament light polypeptide was measured by sandwich enzyme‐linked immunosorbent assay (ELISA) and was reported as “not detected”; the laboratory did not provide a numerical lower limit of detection. The patient was treated with intravenous methylprednisolone, intravenous immunoglobulin, and rituximab, resulting in clinically meaningful improvement. This case highlights the importance of recognizing immune‐dominant anti‐IgLON5 disease. Multimodal imaging and biomarkers can differentiate it from neurodegenerative disorders, enabling early immunotherapy and improved outcomes.

Zitieren

APA

Patel, B., Patel, R., Yadav, M., Susvirkar, A., Jain, A., & Shah, H. (2026). Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease. Neurology and Clinical Neuroscience. https://doi.org/10.1002/ncn3.70176

Vancouver

Patel B, Patel R, Yadav M, Susvirkar A, Jain A, Shah H. Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease. Neurology and Clinical Neuroscience. 2026. doi:10.1002/ncn3.70176

BibTeX
@article{Patel2026,
  author = {Patel, Bhavin and Patel, Rachana and Yadav, Manjusha and Susvirkar, Ashish and Jain, Avani and Shah, Haresh},
  title = {Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease},
  journal = {Neurology and Clinical Neuroscience},
  year = {2026},
  doi = {10.1002/ncn3.70176}
}
Kostenlos starten →